U.S. Household Products Stock News

Pool Corporation (NasdaqGS:POOL) is highlighting its resilience in a tough pool industry backdrop, with flat revenues and weakness in new pool construction. The company is leaning on pricing discipline, supply chain initiatives, and digital efforts to support gross margins and customer service. Ongoing acquisition activity remains part of Pool's growth playbook as it looks to expand its reach and capabilities. Pool, a major distributor of swimming pool supplies, equipment, and related...

In late February 2026, Thryv Holdings filed an US$8.15 million shelf registration for 2,179,185 common shares tied to its ESOP and reported fourth-quarter 2025 results showing quarterly sales of US$191.62 million, a net loss of US$9.66 million, and full-year 2025 sales of US$785.02 million with net income of US$0.31 million. Beyond the headline figures, the results underscored Thryv’s rapid pivot toward higher-margin SaaS and AI-powered tools, with SaaS revenue rising sharply, margins...

Option Care Health, Inc. recently reported its fourth-quarter and full-year 2025 results, with Q4 sales rising to US$1,465.45 million while net income eased slightly to US$58.5 million, and full-year sales increasing to US$5.65 billion alongside modestly higher earnings per share from continuing operations. Alongside these results, the company reaffirmed its 2026 outlook and expanded its share repurchase authorization to US$1 billion, highlighting management’s focus on capital returns even...

First Hawaiian, Inc. recently filed its 2025 10-K, detailing a shift to two core segments, Retail Banking and Commercial Banking, alongside US$129.9 million in dividends and US$100.0 million in share repurchases, reinforcing its current capital allocation priorities. The combination of segment realignment and sizeable capital returns highlights how management is repositioning the bank’s business mix while returning excess capital to shareholders. Next, we’ll examine how the new Retail and...

Fortrea Holdings (FTRE) shares came under pressure after the contract research group reported fourth quarter 2025 results with revenue and adjusted earnings below analyst forecasts, along with full year 2025 and 2026 guidance that trailed market expectations. See our latest analysis for Fortrea Holdings. At a share price of US$10.72, Fortrea has recorded a sharp 30 day share price return of a 37.13% decline and a 1 year total shareholder return of a 22.60% loss. This suggests momentum has...

Silgan Holdings Inc. previously announced that its Board approved a US$0.21 per share quarterly dividend, payable on March 31, 2026 to shareholders of record on March 17, 2026, representing a 5% increase and extending a streak of 88 consecutive quarterly payments since 2004. This 22-year record of annual dividend increases highlights Silgan’s consistent cash generation and its emphasis on returning capital to shareholders alongside ongoing operational initiatives. We’ll now explore how this...

In late February 2026, Butterfly Network, Inc. reported Q4 2025 results showing US$31.51 million in revenue versus US$22.35 million a year earlier, narrower quarterly losses, and issued 2026 revenue guidance of US$117 million to US$121 million alongside a new US$57.00 million shelf registration for ESOP-related Class A shares. The company’s first quarter of positive operating cash flow, boosted by its Midjourney partnership and Compass AI launch, highlights a shift toward higher-margin,...

If you are trying to figure out whether Freshpet at around US$84.45 is a bargain or already pricing in a lot of optimism, you are asking the right question for this stock. The share price performance has been mixed, with a 13.3% return over the last 7 days, 21.2% over 30 days, 40.4% year to date, but a 21.1% decline over 1 year and a 39.4% decline over 5 years. These swings mean recent news and expectations have become a big part of the story, as investors reassess what they are willing to...

United Rentals (NYSE:URI) and Procore Technologies launched a new telematics integration that brings rental equipment data directly into Procore's Resource Management solution. The collaboration connects jobsite equipment usage and location data with project planning tools to support more precise resource allocation. The integration is designed to help contractors address equipment inefficiencies and improve coordination across construction projects. For you as an investor, this move sits...

Cipher Digital, formerly focused on Bitcoin mining, has completed a full pivot to high performance computing infrastructure under the ticker NasdaqGS:CIFR. The company has rebranded, exited its legacy mining stakes, and repositioned itself as an operator of HPC data centers. Cipher Digital has secured long term data center agreements with major cloud providers including AWS, Fluidstack, and Google. The company has raised capital through bond offerings to support its shift toward hyperscale...

If you are wondering whether Napco Security Technologies' current share price reflects its true worth, you are not alone. Many investors are trying to work out if the recent run still leaves room for value. The stock closed at US$46.61, with returns of 1.6% over the last 7 days, 26.3% over 30 days, 12.6% year to date and 92.9% over 1 year. The 3 year and 5 year returns stand at 47.4% and 182.8% respectively. Recent news coverage has largely focused on Napco Security Technologies as a...

If you are looking at NovoCure and wondering whether the recent share price makes sense, this article will walk through what that price might be implying about the stock's value. The shares last closed at US$13.67, with returns of 20.3% over the past 7 days and 10.2% over 30 days, set against a 4.2% return year to date and a 28.3% decline over 1 year, and an 82.5% and 89.4% decline over 3 and 5 years respectively. Recent news coverage around NovoCure has focused on the company as a Nasdaq...

If you are looking at Targa Resources and wondering whether the current share price still makes sense, you are not alone. The stock last closed at US$235.80, with returns of 1.9% over 7 days, 17.3% over 30 days, 26.3% year to date and 19.6% over 1 year, while the 3 year return is very large and the 5 year return is also very large. Recent news flow around Targa Resources has focused on its position in the energy infrastructure space and how investor sentiment has been reflecting that...

If you are wondering whether Recursion Pharmaceuticals' current share price makes sense, the key question is how that price compares with what the business could reasonably be worth. The stock last closed at US$3.67, with a 7 day return of 7.3%, a 30 day return decline of 12.4%, a year to date return decline of 12.6%, and a 1 year return decline of 51.1%. These figures will shape how many investors think about its potential and risk today. Recent coverage has focused on Recursion...

GoodRx Holdings recently reported fourth-quarter 2025 results, issued 2026 revenue guidance of US$750 million to US$780 million, updated progress on its share buyback, filed a US$74.72 million shelf registration for an ESOP-related Class A stock offering, and disclosed several analyst rating changes. The company also launched GoodRx Employer Direct, a new program that lets employers directly subsidize high-cost drugs like GLP-1s at the pharmacy counter, potentially widening GoodRx’s role in...

National HealthCare Corporation reported past fourth-quarter 2025 revenue of US$386.51 million and net income of US$24.85 million, with full‑year 2025 revenue of US$1.52 billion and net income of US$120.02 million, all higher than the prior year. The company highlighted that growth was supported both by higher same‑facility revenues and the contribution from its White Oak Manor acquisition, underscoring the role of expansion alongside core operations in its 2025 results. With this backdrop...

Why Pacira BioSciences is on investors’ radar today Pacira BioSciences (PCRX) has been drawing attention after a mixed share price pattern, with a 6.7% gain over the past month contrasting with negative returns over the past 3 months and year to date. See our latest analysis for Pacira BioSciences. At the current share price of $21.91, Pacira BioSciences shows a mixed picture, with a 6.7% 30 day share price return set against a 10.4% year to date share price decline and a 68.3% five year...

With no fresh headline driving Inter & Co (NasdaqGS:INTR) today, recent performance and fundamentals come into focus as investors weigh its returns profile against revenue of R$5,984.585 and net income of R$1,312.39. See our latest analysis for Inter & Co. Inter & Co’s share price has eased in the short term, with a 7 day share price return of 5.84% and 30 day share price return of 6.65%, yet its 1 year total shareholder return of 64.56% and 3 year total shareholder return of almost 4x...

Concentra Group Holdings Parent, Inc. recently reported its fourth-quarter and full-year 2025 results, with Q4 revenue rising to US$539.08 million and net income to US$34.69 million, while also declaring a US$0.0625 per-share cash dividend payable in March 2026. Management is pairing this earnings momentum with expansion plans focused on smaller, bolt-on acquisitions and a stepped-up de novo clinic pipeline, supported by a new US$100.00 million share repurchase program. We’ll now examine how...

In late February 2026, Axos Financial, a digital-focused US bank, was caught in a broad financial sector downturn after a higher-than-expected January Producer Price Index reading reinforced concerns about persistent inflation and constrained room for near-term Federal Reserve rate cuts. This inflation surprise matters for Axos because sustained elevated rates can pressure bank net interest margins, directly affecting how profitably it turns deposits into loans and other interest-earning...

Agree Realty (ADC) has drawn attention after its recent share performance, with the stock last closing at $80.48. For income focused investors, the real estate investment trust’s profile may warrant a closer look. See our latest analysis for Agree Realty. The recent 11.8% 1 month share price return, on top of an 11.6% year to date share price return, sits alongside a 5 year total shareholder return of 54.4%, suggesting momentum has been building over both shorter and longer horizons. If this...

Xponential Fitness (XPOF) is back in focus after reporting fourth quarter and full year 2025 results, along with 2026 revenue guidance that points to a lower range than the prior year. See our latest analysis for Xponential Fitness. The earnings release and lower 2026 revenue guidance have coincided with sharp share price weakness, with a 1 day share price return of 47.08% decline and a 1 year total shareholder return of 67.75% decline. This points to fading momentum and a reassessment of...

In recent days, Cathay General Bancorp has come under pressure as investors reacted to rising credit risk concerns amid hotter-than-expected inflation data and growing worries over regional banks’ exposure to commercial real estate. What makes this episode especially important is that it coincides with Cathay General’s flat sales and declining earnings per share, sharpening questions about its profitability and growth profile. We’ll now examine how heightened credit risk concerns,...

Earnings, guidance and capital returns in focus Bristow Group (VTOL) just paired its fourth quarter and full year 2025 results with 2026 guidance, a fresh quarterly dividend and details on a recent US$500 million refinancing at a lower coupon. The company reported Q4 2025 sales of US$377.26 million and net income of US$18.42 million, while affirming 2026 revenue expectations in a US$1.58 billion to US$1.69 billion range and maintaining its new US$0.125 quarterly cash dividend. See our latest...